Caldwell Sutter Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$508K Buy
1,222
+79
+7% +$29.3K 0.19% 130
2026
Q1
$309K Buy
1,143
+112
+11% +$33.4K 0.13% 168
2025
Q4
$340K Buy
1,031
+51
+5% +$17.3K 0.14% 148
2025
Q3
$338K Buy
980
+65
+7% +$19.7K 0.14% 152
2025
Q2
$285K Buy
915
+44
+5% +$16.8K 0.13% 157
2025
Q1
$456K Sell
871
-80
-8% -$40.9K 0.22% 117
2024
Q4
$481K Sell
951
-94
-9% -$53.4K 0.22% 114
2024
Q3
$611K Sell
1,045
-16
-2% -$9.05K 0.28% 96
2024
Q2
$540K Buy
1,061
+14
+1% +$6.86K 0.27% 102
2024
Q1
$518K Sell
1,047
-1,002
-49% -$509K 0.25% 106
2023
Q4
$1.08M Buy
2,049
+152
+8% +$81.1K 0.55% 53
2023
Q3
$956K Sell
1,897
-1
-0.1% -$492 0.53% 52
2023
Q2
$912K Buy
1,898
+638
+51% +$312K 0.48% 59
2023
Q1
$595K Buy
1,260
+110
+10% +$53.1K 0.43% 59
2022
Q4
$610K Buy
+1,150
New +$609K 0.54% 54

Other funds holding UNH

Caldwell Sutter Capital's UNH Position: Q2 2026 in Review

Caldwell Sutter Capital increased its UnitedHealth (UNH) stake by 6.9% in Q2 2026, buying an estimated $29.3K and bringing the position to 1,222 shares worth $508K. The position accounts for 0.19% of the portfolio, ranked #130.

Caldwell Sutter Capital first reported a position in UNH in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.08M in Q4 2023. 3,392 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Caldwell Sutter Capital held 1,222 shares of UnitedHealth worth $508K as of Q2 2026.
  • Caldwell Sutter Capital bought 79 UnitedHealth shares in Q2 2026, an estimated $29.3K.
  • UnitedHealth made up 0.19% of Caldwell Sutter Capital's portfolio in Q2 2026, its #130 holding.
  • Caldwell Sutter Capital first reported a position in UnitedHealth in Q4 2022 and has held it in 15 quarters since.
  • Caldwell Sutter Capital's UnitedHealth position peaked at $1.08M in Q4 2023.
  • 3,392 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.